A Functionally Distinct CXCR3⁺/IFN-γ⁺/IL-10⁺ Subset Defines Disease-Suppressive Myelin-Specific CD8 T Cells

Area of Science:

• Immunology
• Neuroscience
• Cell Biology

Background:

• Multiple sclerosis (MS) is an immune-mediated CNS demyelinating disease.
• CNS-specific CD8 T cells can suppress disease in MS and its animal model, experimental autoimmune encephalomyelitis (EAE).
• Phenotypic definitions of regulatory CD8 T cell subsets in autoimmune diseases remain varied.

Purpose of the Study:

• To delineate unique phenotypic properties of disease-suppressive CNS-specific regulatory CD8 T cells (PLP_178-191) compared to nonregulatory CD8 T cells (PLP_139-151 and OVA_323-339) in a relapsing-remitting EAE model.
• To identify specific markers associated with the regulatory function of CD8 T cells in the context of MS.

Main Methods:

• Utilized multiparametric flow cytometry to analyze phenotypic marker expression on CD8 T cell subsets.
• Compared regulatory PLP_178-191 CD8 T cells with nonregulatory PLP_139-151 and OVA_323-339 CD8 T cells in a relapsing-remitting EAE model.
• Investigated similar subsets in C57BL/6 mice using PLP_178-191 and OVA_323-339 CD8 T cells.

Main Results:

• Identified a CXCR3⁺ subpopulation within activated regulatory CD8 T cells, distinct from nonregulatory counterparts.
• This CXCR3⁺ subset demonstrated increased degranulation and co-production of IFN-γ and IL-10.
• A similar CXCR3⁺ regulatory CD8 T cell subset was observed in C57BL/6 mice.

Conclusions:

• A specific CXCR3⁺ CD8 T cell subpopulation possesses disease-suppressive functions relevant to MS.
• This finding provides deeper insight into the mechanisms of CD8 T cell-mediated immune regulation.
• Targeting and enhancing this regulatory CD8 T cell subset presents a potential novel immunotherapeutic strategy for multiple sclerosis.